Topoisomerase IIα inhibitor and intracellular ion chelator
Related Products
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Dexrazoxane

Item No. 14632

Technical Information
Formal Name
4,4'-[(1S)-1-methyl-1,2-ethanediyl]bis-2,6-piperazinedione
CAS Number
24584-09-6
Synonyms
  • ICRF 187
  • NSC 169780
Molecular Formula
C11H16N4O4
Formula Weight
Purity
≥98%
A crystalline solid
DMF: 5 mg/mlDMSO: 10 mg/mlPBS (pH 7.2): 0.25 mg/ml
SMILES
O=C(N1)CN(C[C@H](C)N2CC(NC(C2)=O)=O)CC1=O
InChi Code
InChI=1S/C11H16N4O4/c1-7(15-5-10(18)13-11(19)6-15)2-14-3-8(16)12-9(17)4-14/h7H,2-6H2,1H3,(H,12,16,17)(H,13,18,19)/t7-/m0/s1
InChi Key
BMKDZUISNHGIBY-ZETCQYMHSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    Dexrazoxane is an intracellular iron chelator and an inhibitor of topoisomerase IIα.1 Through these activities, dexazoxane is highly protective in reducing anthracycline-induced cardiotoxicity and extravasation injury.2 Dexrazoxane has also been shown to act as an antioxidant that scavenges hydroxyl (IC50 = 2.1 mM), superoxide (IC50 = 0.4 mM), lipid (IC50 = 4.4 mM), 2,2-diphenyl-1-picrylhydrazyl (IC50 = 3.5 μM), and 2,2’-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid) (IC50 = 3.8 mM) free radicals.3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Yan, T., Deng, S., Metzger, A., et alTopoisomerase IIα-dependent and -independent apoptotic effects of dexrazoxane and doxorubicin. Mol. Cancer Ther. 8(5), 1075-1085 (2009).

    2. Kurz, T., Grant, D., Andersson, R.G.G., et alEffects of MnDPDP and ICRF-187 on doxorubicin-induced cardiotoxicity and anticancer activity. Transl. Oncol. 5(4), 252-259 (2012).

    3. Junjing, Z., Yan, Z., and Baolu, Z. Scavenging effects of dexrazoxane on free radicals. J. Clin. Biochem. Nutr. 47(3), 238-245 (2010).